Jasper Therapeutics (JSPR) Treasury Shares (2019 - 2026)
Jasper Therapeutics (JSPR) posted Treasury Shares of $550000.0 for Q2 2026, little changed on a QoQ basis from $550000.0 in Q4 2025, and little changed year-over-year from $550000.0 in Q2 2025.
Analysis
Jasper Therapeutics (JSPR) Treasury Shares (2019 - 2026) Analysis & Trends
Jasper Therapeutics has reported Treasury Shares for 7 years, with the latest figure at $550000.0 in Q2 2026.
- On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $550000.0 in Q2 2026; TTM through Jun 2026 was $550000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $550000.0, changed 0.0% from the prior year.
- Treasury Shares was $550000.0 for Q2 2026 at Jasper Therapeutics, roughly flat from $550000.0 in the prior quarter.
- The five-year high for Treasury Shares was $5.5 million in Q3 2023, with the low at $550000.0 in Q4 2023.
- Average Treasury Shares over 4 years is $1.0 million, with a median of $550000.0 recorded in 2023.
- The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 90.0% in 2024.
- Over 4 years, Treasury Shares stood at $550000.0 in 2023, then changed by 0.0% to $550000.0 in 2024, then changed by 0.0% to $550000.0 in 2025, then changed by 0.0% to $550000.0 in 2026.
- The last three Treasury Shares figures came in at $550000.0 (Q2 2026), $550000.0 (Q4 2025), and $550000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Jasper Therapeutics | 20.11 Mn | 20.11 Mn | - | 550,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 550,000.00 |
| Jun 30, 2026 | 550,000.00 |
| Dec 31, 2025 | 550,000.00 |
| Dec 31, 2025 | 550,000.00 |
| Sep 30, 2025 | 550,000.00 |
| Sep 30, 2025 | 550,000.00 |
| Jun 30, 2025 | 550,000.00 |
| Jun 30, 2025 | 550,000.00 |
| Mar 31, 2025 | 550,000.00 |
| Mar 31, 2025 | 550,000.00 |
| Dec 31, 2024 | 550,000.00 |
| Dec 31, 2024 | 550,000.00 |
| Sep 30, 2024 | 550,000.00 |
| Sep 30, 2024 | 550,000.00 |
| Jun 30, 2024 | 550,000.00 |
| Jun 30, 2024 | 550,000.00 |
| Mar 31, 2024 | 550,000.00 |
| Mar 31, 2024 | 550,000.00 |
| Dec 31, 2023 | 550,000.00 |
| Dec 31, 2023 | 550,000.00 |